Last $7.56 USD
Change Today +0.20 / 2.72%
Volume 800.7K
INO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

inovio pharmaceuticals inc (INO) Key Developments

Inovio Pharmaceuticals, Inc. Appoints Nancy Wysenski to its Board of Directors

Inovio Pharmaceuticals, Inc. announced that Nancy Wysenski joined its Board of Directors. Ms. Wysenski, a commercial pharmaceutical executive, has over 30 years' experience in the pharmaceutical industry and has launched numerous new products. Ms. Wysenski previously served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals where she led the effort to build the commercial infrastructure and launched Incivek and Kalydeco.

Inovio Pharmaceuticals, Inc. Presents at 22nd Annual Emerald Groundhog Day Investment Forum, Feb-05-2015 02:45 PM

Inovio Pharmaceuticals, Inc. Presents at 22nd Annual Emerald Groundhog Day Investment Forum, Feb-05-2015 02:45 PM. Venue: Radisson Blu - Warwick Hotel, Philadelphia, Pennsylvania, United States.

Inovio Pharmaceuticals, Inc. Appoints Mark Stephen Gelder as Vice President of Clinical Development

Inovio Pharmaceuticals, Inc. announced it has appointed Mark Stephen Gelder, M.D. as Vice President, Clinical Development. Dr. Gelder will be responsible for planning and executing Inovio's clinical development strategy for its immunotherapies against human papillomavirus (HPV)-caused cervical cancer and dysplasia. He will report to Dr. Mark Bagarazzi, Inovio's Chief Medical Officer. Dr. Gelder's previous experience includes therapeutic oncology programs at Pfizer, Wyeth and Bayer.

Inovio Pharmaceuticals, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 09:30 AM

Inovio Pharmaceuticals, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 09:30 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: J. Joseph Kim, Chief Executive Officer, President, Director and Member of Finance Committee.

Inovio Pharmaceuticals, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015

Inovio Pharmaceuticals, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 . Venue: Westin St. Francis Hotel, San Francisco, California, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $7.56 USD +0.20

INO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advaxis Inc $11.10 USD +0.51
Dynavax Technologies Corp $21.56 USD +0.255
GenVec Inc $3.26 USD -0.04
Transgene SA €7.00 EUR +0.05
Vical Inc $1.03 USD +0.02
View Industry Companies
 

Industry Analysis

INO

Industry Average

Valuation INO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 45.6x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 35.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.